Terrific work by my dream team Gurleen Kaur, MD & Diane Masket, MS Tina Reddy Sharon Mulvagh MD FRCPC FASE FACC Shelley Zieroth @DrM_Odonoghue Dr. Michael Farkouh et al. CJC Journals

Socioeconomic Disparities in Women’s Cardiovascular Health in United States🇺🇸 & Canada🇨🇦
📎rb.gy/023rm5

Hey, Cardiac Critical Care Nerds! ❤️🚨🤓

The UMN Critical Care Cardiology Education Summit is May 29-31 and this CardioNerds crew is so excited to learn with you.

Follow us for live updates as we learn from leaders in the CCC community. #CCCES2024

🎉 We can’t wait! 🎉

The gang in #AAIM Chief Resident Conference Cleveland Clinic IM #MedEd Joe Sipko, MD Brandon Francis Ian Persits, DO, MS Mohammad Alamer and Mariah (No twitter yet) Richard M. Wardrop III, MD, PhD, FAAP, FACP, SFHM

Absorbing all the chief wisdom with this crew + Mariah (no twitter) #AAIM Richard M. Wardrop III, MD, PhD, FAAP, FACP, SFHM Cleveland Clinic IM Mohammad Alamer Joe Sipko, MD Michael Yim, MD Brandon Francis

It was a busy weekend, but grateful for the opportunity to represent residents/fellows at the Ohio State Medical annual meeting with Michelle I. Knopp, MD (she/her)! I was excited to see progress on firearm safety, naloxone availability, and transgender and reproductive rights, among many more issues!

Deadline tomorrow! f you're a Fellow, Resident, or Student Interested in VTE, consider applying for The PERT Consortium's Trainee Council.

Take the first step towards shaping the future of VTE care: pertconsortium.org/pert-trainee-c…

James Horowitz
F Mae West, MD MS
Rachel Rosovsky

Highly recommended for all #MedStudentTwitter interested in 🫀. This is a phenomenal community that has impacted my life in such positive ways

It was wonderful seeing so many #ACCMedStudents at #ACC24 - the community is strong going into Yr 4 and we are looking for the new team that will take it to the next level! If you’re interested in being a leadership member, please APPLY. The April 19th deadline is approaching. 🫀

Thrilled to share that the new 2024 EHRA guidelines now recommend shortening the blanking period from 12 to 8 weeks, partially based on our recent publication Nassir Marrouche Eoin Donnellan Europace Editor-in-Chief doi.org/10.1093/europa….

'We’re enabling the selected companies to leverage Google’s most advanced AI technologies - and in the case of Glass Health, to empower providers and patients with AI to improve health outcomes at scale.”✨

- Matt Ridenour, Head of Startup Ecosystem, USA, Google for Startups

Awesome time at ACC in Atlanta. Special thanks to W. H. Wilson Tang, MD Saeid Mirzai Kunaal Sarnaik and Maximillian C. Volk (my curricular chief successor) #ACC2024 Richard M. Wardrop III, MD, PhD, FAAP, FACP, SFHM Cleveland Clinic IM heba wassif Andrew Higgins Penelope Rampersad MD, MSc, FRCPC, FACC Ran Lee

Read about the inaugural cohort of fifteen pioneering AI startups, including glass.health, who have joined the Google for Startups Accelerator: AI First North America.✨

developers.googleblog.com/2024/04/meet-g…

Glass Health is thrilled to be 1 of 15 startups in the USA selected for the Google for Startups Accelerator: AI First Program!

blog.glass.health/glass-health-j…

#AcceleratedWithGoogle Google Cloud Google Cloud Partners

1/12 - Mystery #1

You are seeing a patient recently diagnosed with heart failure and started on GDMT. You notice that their hemoglobin (HGB) has increased (12 → 13 g/dL) in the intervening weeks.

🤔Which medication is the likely cause of this increase in HGB?

La experiencia del servicio social de medicina en México refleja un sistema de salud roto y precario. Esta política no ha cambiado en décadas por que los estudiantes que lo viven no son escuchados.

En nuestro editorial hoy en The Lancet, exponemos al mundo la problemática que…

Had a blast as usual at #ACC2024 American College of Cardiology in Atlanta
Always thrilled to present our work and happy to reconnect with old friends and colleagues Cleveland Clinic IM
Richard M. Wardrop III, MD, PhD, FAAP, FACP, SFHM Cleveland Clinic Heart, Vascular & Thoracic

#ACC24 PREVENT discusses non flow-limiting high-risk plaque evaluating, though note stenosis highlighted in presentation!

What does this say about utilization/relevance of FFR/iFR on outcomes?

So many questions following this trial

What a CardioRheum session!

Fantastic talk on:

ASCVD risk stratification/management on rheum disease (RA/SLE) by Brittany Weber

Imaging modalities in large vessel vasculitis by Dr. Osborne

Two cardiac inflammation extraordinaire!

#ACC24

#ACC24 American College of Cardiology
PROACT trial . Presented by Dr. Austin
✅Adding Enalapril to standard of care was NOT superior to standard care alone in the prevention of cardio-toxicity in patients receiving high dose Anthracycline based chemotherapy Richard Ferraro Ritu Thamman MD

#ACC24 PREVENT trial is up and it's a big one

PCI for non-flowing limiting, high-risk is shows ⬇️ cardiovascular events!

Wow this is certain to generate discussion. Implications for management could be huge